[Federal Register Volume 83, Number 196 (Wednesday, October 10, 2018)]
[Notices]
[Page 50886]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-21981]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-34-2018]


Foreign-Trade Zone (FTZ) 230--Greensboro, North Carolina, 
Authorization of Production Activity, Patheon Softgels (Pharmaceutical 
Products), High Point, North Carolina

    On May 31, 2018, The Piedmont Triad Partnership, grantee of FTZ 
230, submitted a notification of proposed production activity to the 
FTZ Board on behalf of Patheon Softgels, within Subzone 230C, in High 
Point, North Carolina.
    The notification was processed in accordance with the regulations 
of the FTZ Board (15 CFR part 400), including notice in the Federal 
Register inviting public comment (83 FR 26947, June 11, 2018). On 
September 28, 2018, the applicant was notified of the FTZ Board's 
decision that no further review of the activity is warranted at this 
time. The production activity described in the notification was 
authorized, subject to the FTZ Act and the FTZ Board's regulations, 
including Section 400.14.

    Dated: October 1, 2018.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2018-21981 Filed 10-9-18; 8:45 am]
 BILLING CODE 3510-DS-P